Showing posts with label Journal of Neonatology and Clinical Pediatrics. Show all posts
Showing posts with label Journal of Neonatology and Clinical Pediatrics. Show all posts

Thursday, 8 April 2021

Lupine Publishers | Approach to Neurodegenerative Disease in Children: A Short Review

 Lupine Publishers | Journal of Pediatrics and Neonatology


Abstract

Neurodegenerative disorders of childhood are complicated diseases with wide range of systematic involvement. These diseases often pose great challenge to clinicians in terms of diagnosis and management. The purpose of this article is to outline a systematic approach to a child presenting with suspected neurodevelopmental regression. Many inherited metabolic disorders present with neural regression. The clinical approach depends upon the age of presentation, site of involvement in brain. Sound clinical knowledge and better approach leads to early diagnosis, better management and above all genetic counselling. As the medical science is in the track of rapid progression several treatment modalities are in the pipeline for neurodegenerative syndromes, early diagnosis and referral to higher centres can bring a better future to the child.

Keywords: Neurodegenerative diseases; Hepatomegaly; White Matter; Grey Matter

Introduction

Neurodegenerative disorders of childhood include large, heterogeneous group of diseases that result from specific genetic and biochemical defects, chronic viral infections, and varied unknown causes. The hallmark of a neurodegenerative disease is regression and progressive deterioration of neurologic function with loss of speech, vision, hearing, or locomotion, often associated with seizures, feeding difficulties, and impairment of intellect [1]. The acquisition of new developmental milestones does not exclude the existence of a degenerative disorder. Most degenerative CNS disorders can be divided clinically into three groups: gray-matter diseases, white-matter diseases, and system diseases [1,2] (Tables 1-3).

Table 1:Area of brain involvement.

lupinepublishers-openaccess-journal-pediatrics-neonatology

Table 2:Approach according to age of presentation [4].

lupinepublishers-openaccess-journal-pediatrics-neonatology

Table 3:Treatable conditions with neural regression [5] loss of social skills.

lupinepublishers-openaccess-journal-pediatrics-neonatology

Classification

Approach to Child with Marked Regression

a) History: In a patient with developmental regression the history is very vital. Clues for diagnosis lie in the history. First step would be to ascertain the age of onset of regression and the acquisition of various milestones prior to that. Was the child completely normal before regression or was there a concern regarding development even prior to regression? Did the child attained milestones before losing it. Which milestones the child lost? In autism and other pervasive developmental disorders regression of language skills is noted first followed by loss of social skills (Tables 4 & 5).

Table 4:Specific pointers in history.

lupinepublishers-openaccess-journal-pediatrics-neonatology

Table 5:Individual disease and clues for diagnosis.

lupinepublishers-openaccess-journal-pediatrics-neonatology

Thursday, 27 September 2018

Winning the War on Cancer (PAPN) - Lupine Publishers




A new study has uncovered how brain injury can be worsened by bacteria in the gut. The gut-brain connection is one of the more fascinating new areas of medical research. This intriguing two-way axis has been found to have numerous unexpected effects. On one hand some studies have demonstrated how magnetic brain stimulation can alter person's gut microbiome while other studies have shown how gut bacteria could potentially play a role in the onset of PTSD (post traumatic stress syndrome) and Alzheimer's. Studies in patients and subsequent mouse research really drive home that our gut microbiomes modulate both systemic and anti-tumor immunity, said Jennifer Wargo, a surgical oncologist and geneticist at the University of Texas MD Anderson Cancer Center. She is planning clinical trials to see if fecal transplant in cancer patients could improve immunotherapy success rates. The main conclusion from this is: You can change your microbiome.



Thursday, 20 September 2018

Neonatal Care and the Issue of Disclosure of Information (PAPN) - Lupine Publishers



There is little doubt that the field of Neonatology has, and is, undergoing vast clinical changes as underlying research in all its background sciencesprogresses in leaps and bounds. One has also to realise that this progress as in all medical disciplines is multi-dimensional, and far beyond the simple clinical end-point expression of progress in neonatal medicine, pharmacology and surgery. Among these dimensions, the medico-legal aspect, looms large and over the recent years, has loomed larger still.